ConductScience.org, home

Paper39765351

[Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau].

He QY and 13 others. Zhonghua Xue Ye Xue Za Zhi, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau]. Papers, record 39765351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39765351

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau].
PubMed
Journal
Zhonghua Xue Ye Xue Za Zhi
PubMed
Year
2024
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2025-03-09
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1He QYQ Y
2Lai ALA L
3Zhang AA
4Wang LNL N
5GesangquzhenGroup
6PingcuozhuogaGroup
7CirenGroup
8Chen XMX M
9YixilamuGroup
10Qiu SWS W
11Wei HH
12Wang JXJ X
13BaimayangjinGroup
14Zhang GJG J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Humans
Retrospective Studies
Prognosis
Treatment Outcome
Tibet
Survival Analysis
Male
Female
Survival Rate

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022-RW320-14Non-profit Central Research Institute Fund of Chinese Academy of Medical SciencesPubMed
2023NCRCA0101Clinical Research Foundation of National Clinical Research Center for Blood DiseasesPubMed
2021YFC2500300National Key Research and Development Program of ChinaPubMed

Source PubMed

Download CSV of grants

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122412151Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.J Clin Oncol2012https://conductscience.org/library/papers/22412151PubMed
237424223Novel precision medicine approaches and treatment strategies in hematological malignancies.J Intern Med2023https://conductscience.org/library/papers/37424223PubMed
334551384Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021https://conductscience.org/library/papers/34551384PubMed
435680595[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].Zhonghua Xue Ye Xue Za Zhi2022https://conductscience.org/library/papers/35680595PubMed
518502832
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood2008https://conductscience.org/library/papers/18502832PubMed
629563537Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies.Leukemia2018https://conductscience.org/library/papers/29563537PubMed
729562460[Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2018)].Zhonghua Xue Ye Xue Za Zhi2018https://conductscience.org/library/papers/29562460PubMed
824127444Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.J Clin Oncol2013https://conductscience.org/library/papers/24127444PubMed
935797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
1031113776The simpler, the better: oral arsenic for acute promyelocytic leukemia.Blood2019https://conductscience.org/library/papers/31113776PubMed
1132461631Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.Leukemia2020https://conductscience.org/library/papers/32461631PubMed
1233085860Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.N Engl J Med2020https://conductscience.org/library/papers/33085860PubMed
1329905379Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.Am J Hematol2018https://conductscience.org/library/papers/29905379PubMed
1423716539Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.Haematologica2013https://conductscience.org/library/papers/23716539PubMed
1527276561Genomic Classification and Prognosis in Acute Myeloid Leukemia.N Engl J Med2016https://conductscience.org/library/papers/27276561PubMed
1616407512Treatment of acute lymphoblastic leukemia.N Engl J Med2006https://conductscience.org/library/papers/16407512PubMed
1731495127[Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old].Zhonghua Xue Ye Xue Za Zhi2019https://conductscience.org/library/papers/31495127PubMed
1834193815Acute promyelocytic leukemia current treatment algorithms.Blood Cancer J2021https://conductscience.org/library/papers/34193815PubMed
1925871894Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.Chemotherapy2014https://conductscience.org/library/papers/25871894PubMed
2035834222Treatment of Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-From Intensive Chemotherapy Combinations to Chemotherapy-Free Regimens: A Review.JAMA Oncol2022https://conductscience.org/library/papers/35834222PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CEBPZ10153PubTator's text mininghttps://conductscience.org/library/genes/10153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39765351

GET https://conductscience.org/api/papers/v1/39765351/authors